These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12153170

  • 21. ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease.
    Zinzani PL, Magagnoli M, Frezza G, Barbieri E, Gherlinzoni F, Galuppi A, Bendandi M, Merla E, Albertini P, Babini L, Tura S.
    Leuk Lymphoma; 1999 Feb; 32(5-6):553-9. PubMed ID: 10048428
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
    Engert A, Plütschow A, Eich HT, Lohri A, Dörken B, Borchmann P, Berger B, Greil R, Willborn KC, Wilhelm M, Debus J, Eble MJ, Sökler M, Ho A, Rank A, Ganser A, Trümper L, Bokemeyer C, Kirchner H, Schubert J, Král Z, Fuchs M, Müller-Hermelink HK, Müller RP, Diehl V.
    N Engl J Med; 2010 Aug 12; 363(7):640-52. PubMed ID: 20818855
    [Abstract] [Full Text] [Related]

  • 24. Interdigitating dendritic cell sarcoma presenting in the nasal region.
    Parada D, Peña KB, Gil I, Queralt R, Garcia A, Alos L.
    Pathol Res Pract; 2012 Jun 15; 208(6):368-71. PubMed ID: 22554504
    [Abstract] [Full Text] [Related]

  • 25. Interdigitating dendritic cell sarcoma of the spleen with hepatic failure after chemotherapy: A case report.
    Zhao C, Xie X, Gai DZ, Wu D, Xin H, Yang T.
    Medicine (Baltimore); 2019 May 15; 98(19):e15535. PubMed ID: 31083204
    [Abstract] [Full Text] [Related]

  • 26. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Hutchinson RJ, Fryer CJ, Davis PC, Nachman J, Krailo MD, O'Brien RT, Collins RD, Whalen T, Reardon D, Trigg ME, Gilchrist GS.
    J Clin Oncol; 1998 Mar 15; 16(3):897-906. PubMed ID: 9508171
    [Abstract] [Full Text] [Related]

  • 27. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL, Glatstein E, Duffey PL, Young RC, Ihde DC, Bastian AW, Wilson WH, Wittes RE, Jaffe ES, Hubbard SM, DeVita VT.
    J Clin Oncol; 1997 Nov 15; 15(11):3338-46. PubMed ID: 9363863
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D, Tesch H, Herrmann R, Dörken B, Müller-Hermelink HK, Dühmke E, Loeffler M, German Hodgkin's Lymphoma Study Group.
    N Engl J Med; 2003 Jun 12; 348(24):2386-95. PubMed ID: 12802024
    [Abstract] [Full Text] [Related]

  • 30. Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy.
    Suzuki T, Takeuchi M, Saeki H, Yamazaki S, Koga H, Abe D, Nishimura M, Nakaseko C, Nakasa H, Nakamura H, Ariyoshi N, Kitada M.
    Clin Ther; 2010 Mar 12; 32(3):527-31. PubMed ID: 20399989
    [Abstract] [Full Text] [Related]

  • 31. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
    Carde P, Hagenbeek A, Hayat M, Monconduit M, Thomas J, Burgers MJ, Noordijk EM, Tanguy A, Meerwaldt JH, Le Fur R.
    J Clin Oncol; 1993 Nov 12; 11(11):2258-72. PubMed ID: 7693881
    [Abstract] [Full Text] [Related]

  • 32. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
    Somers R, Carde P, Henry-Amar M, Tarayre M, Thomas J, Hagenbeek A, Monconduit M, de Pauw BE, Breed WP, Verdonck L.
    J Clin Oncol; 1994 Feb 12; 12(2):279-87. PubMed ID: 7509381
    [Abstract] [Full Text] [Related]

  • 33. Interdigitating dendritic cell sarcoma. A report of four cases and review of the literature.
    Gaertner EM, Tsokos M, Derringer GA, Neuhauser TS, Arciero C, Andriko JA.
    Am J Clin Pathol; 2001 Apr 12; 115(4):589-97. PubMed ID: 11293908
    [Abstract] [Full Text] [Related]

  • 34. Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.
    Pavlovsky S, Corrado C, Pavlovsky MA, Prates MV, Zoppegno L, Giunta M, Cerutti I, Palomino E, Pagani F, Lastiri F, Bar D, Bezares RF, Avila G.
    Clin Lymphoma Myeloma Leuk; 2010 Jun 12; 10(3):181-5. PubMed ID: 20511162
    [Abstract] [Full Text] [Related]

  • 35. Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy.
    Karmiris TD, Grigoriou E, Tsantekidou M, Spanou E, Mihalakeas H, Baltadakis J, Apostolidis J, Pagoni M, Karakasis D, Bakiri M, Mitsouli C, Harhalakis N, Nikiforakis E.
    Leuk Lymphoma; 2003 Sep 12; 44(9):1523-8. PubMed ID: 14565654
    [Abstract] [Full Text] [Related]

  • 36. Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study.
    Rueda A, Alba E, Ribelles N, Sevilla I, Ruiz I, Miramón J.
    J Clin Oncol; 1997 Mar 12; 15(3):1118-22. PubMed ID: 9060553
    [Abstract] [Full Text] [Related]

  • 37. [Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
    Kharchenko VP, Datsenko PV, Panyshin GA, Sotnikov VM, Mel'nik IuD.
    Vopr Onkol; 2006 Mar 12; 52(5):531-7. PubMed ID: 17168361
    [Abstract] [Full Text] [Related]

  • 38. Interdigitating cell sarcoma. A morphologic, immunohistologic, and enzyme-histochemical study.
    Nakamura S, Hara K, Suchi T, Ito M, Ikeda H, Nagahama M, Nakayama A, Nakagawa A, Kaneshima H, Asai J.
    Cancer; 1988 Feb 01; 61(3):562-8. PubMed ID: 3338024
    [Abstract] [Full Text] [Related]

  • 39. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP.
    Semin Oncol; 1990 Feb 01; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [Abstract] [Full Text] [Related]

  • 40. [A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
    Ziółko E.
    Pol Merkur Lekarski; 1997 Jul 01; 3(13):8-9. PubMed ID: 9432303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.